XML 87 R81.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Oct. 31, 2019
Jul. 31, 2019
Apr. 30, 2019
Jan. 31, 2019
Oct. 31, 2018
Jul. 31, 2018
Apr. 30, 2018
Jan. 31, 2018
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Segment Reporting Information [Line Items]                      
Net sales $ 691.6 $ 679.4 $ 654.3 $ 628.1 $ 651.5 $ 660.0 $ 631.3 $ 590.0 $ 2,653.4 $ 2,532.8 $ 2,139.0
Operating income (loss)                 546.7 403.1 429.1
Interest expense                 68.0 82.7 33.4
Other expense (income), net                 1.3 (11.5) 1.7
Income before income taxes                 477.4 331.9 394.0
Identifiable assets 6,274.5       6,112.8       6,274.5 6,112.8 4,858.7
Depreciation expense                 135.0 128.4 120.0
Amortization expense                 145.8 146.7 68.4
Capital expenditures                 292.1 193.6 127.2
CooperVision                      
Segment Reporting Information [Line Items]                      
Net sales                 1,972.9 1,882.0 1,674.1
CooperSurgical                      
Segment Reporting Information [Line Items]                      
Net sales                 680.5 650.8 464.9
Corporate                      
Segment Reporting Information [Line Items]                      
Net sales                 0.0 0.0 0.0
Operating income (loss)                 (47.6) (56.8) (47.8)
Identifiable assets 173.1       165.1       173.1 165.1 188.6
Depreciation expense                 0.2 0.2 0.3
Amortization expense                 0.0 0.0 0.0
Capital expenditures                 0.0 0.1 0.1
Operating Segments | CooperVision                      
Segment Reporting Information [Line Items]                      
Net sales                 1,972.9 1,882.0 1,674.1
Operating income (loss)                 506.4 479.8 418.4
Identifiable assets 3,911.6       3,746.0       3,911.6 3,746.0 3,562.6
Depreciation expense                 125.8 120.1 115.0
Amortization expense                 40.9 43.6 36.7
Capital expenditures                 259.0 178.4 108.2
Operating Segments | CooperSurgical                      
Segment Reporting Information [Line Items]                      
Net sales                 680.5 650.8 464.9
Operating income (loss)                 87.9 (19.9) 58.5
Identifiable assets $ 2,189.8       $ 2,201.7       2,189.8 2,201.7 1,107.5
Depreciation expense                 9.0 8.1 4.7
Amortization expense                 104.9 103.1 31.7
Capital expenditures                 $ 33.1 $ 15.1 $ 18.9